The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment
The tumor microenvironment is profoundly immunosuppressive. We show that multiple tumor types create intratumoral immune suppression driven by a specialized form of regulatory T cell (Treg) activation dependent on the PTEN (phosphatase and tensin homolog) lipid phosphatase. PTEN acted to stabilize T...
Gespeichert in:
Veröffentlicht in: | Science advances 2015-11, Vol.1 (10), p.e1500845-e1500845 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e1500845 |
---|---|
container_issue | 10 |
container_start_page | e1500845 |
container_title | Science advances |
container_volume | 1 |
creator | Sharma, Madhav D Shinde, Rahul McGaha, Tracy L Huang, Lei Holmgaard, Rikke B Wolchok, Jedd D Mautino, Mario R Celis, Esteban Sharpe, Arlene H Francisco, Loise M Powell, Jonathan D Yagita, Hideo Mellor, Andrew L Blazar, Bruce R Munn, David H |
description | The tumor microenvironment is profoundly immunosuppressive. We show that multiple tumor types create intratumoral immune suppression driven by a specialized form of regulatory T cell (Treg) activation dependent on the PTEN (phosphatase and tensin homolog) lipid phosphatase. PTEN acted to stabilize Tregs in tumors, preventing them from reprogramming into inflammatory effector cells. In mice with a Treg-specific deletion of PTEN, tumors grew slowly, were inflamed, and could not create an immunosuppressive tumor microenvironment. In normal mice, exposure to apoptotic tumor cells rapidly elicited PTEN-expressing Tregs, and PTEN-deficient mice were unable to maintain tolerance to apoptotic cells. In wild-type mice with large established tumors, pharmacologic inhibition of PTEN after chemotherapy or immunotherapy profoundly reconfigured the tumor microenvironment, changing it from a suppressive to an inflammatory milieu, and tumors underwent rapid regression. Thus, the immunosuppressive milieu in tumors must be actively maintained, and tumors become susceptible to immune attack if the PTEN pathway in Tregs is disrupted. |
doi_str_mv | 10.1126/sciadv.1500845 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4640592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1749601164</sourcerecordid><originalsourceid>FETCH-LOGICAL-p181t-b7917fbf644689e93642a32a1657600b54e2b4ee0efa7d114a7da2f7a94dbd513</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdRbKm9epQ9emnd3exukosgpX5AUQ8RvIVJMmlXkmzcTSL990asopeZYT6ed3gJOedsybnQVz43UAxLrhiLpDoiUxGEaiGUjI7_1BMy9_6NMcal1orHp2QitGacSzElr8kO6XOyfqQtdLsP2FPT0MTh1lPjKdDcmc7kUNHCmQEdtSXtxgvft61D78ce7fraOlqb3FlsBuNsU2PTnZGTEiqP80OekZfbdbK6X2ye7h5WN5tFyyPeLbIw5mGZlVpKHcUYB1oKCARwrULNWKYkikwiMiwhLMafxwiiDCGWRVYoHszI9Te37bMai3yUdlClrTM1uH1qwaT_J43ZpVs7pFJLpmIxAi4PAGffe_RdWhufY1VBg7b3KQ9l_OWWluPqxV-tX5EfO4NP0-R6Jw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1749601164</pqid></control><display><type>article</type><title>The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Sharma, Madhav D ; Shinde, Rahul ; McGaha, Tracy L ; Huang, Lei ; Holmgaard, Rikke B ; Wolchok, Jedd D ; Mautino, Mario R ; Celis, Esteban ; Sharpe, Arlene H ; Francisco, Loise M ; Powell, Jonathan D ; Yagita, Hideo ; Mellor, Andrew L ; Blazar, Bruce R ; Munn, David H</creator><creatorcontrib>Sharma, Madhav D ; Shinde, Rahul ; McGaha, Tracy L ; Huang, Lei ; Holmgaard, Rikke B ; Wolchok, Jedd D ; Mautino, Mario R ; Celis, Esteban ; Sharpe, Arlene H ; Francisco, Loise M ; Powell, Jonathan D ; Yagita, Hideo ; Mellor, Andrew L ; Blazar, Bruce R ; Munn, David H</creatorcontrib><description>The tumor microenvironment is profoundly immunosuppressive. We show that multiple tumor types create intratumoral immune suppression driven by a specialized form of regulatory T cell (Treg) activation dependent on the PTEN (phosphatase and tensin homolog) lipid phosphatase. PTEN acted to stabilize Tregs in tumors, preventing them from reprogramming into inflammatory effector cells. In mice with a Treg-specific deletion of PTEN, tumors grew slowly, were inflamed, and could not create an immunosuppressive tumor microenvironment. In normal mice, exposure to apoptotic tumor cells rapidly elicited PTEN-expressing Tregs, and PTEN-deficient mice were unable to maintain tolerance to apoptotic cells. In wild-type mice with large established tumors, pharmacologic inhibition of PTEN after chemotherapy or immunotherapy profoundly reconfigured the tumor microenvironment, changing it from a suppressive to an inflammatory milieu, and tumors underwent rapid regression. Thus, the immunosuppressive milieu in tumors must be actively maintained, and tumors become susceptible to immune attack if the PTEN pathway in Tregs is disrupted.</description><identifier>ISSN: 2375-2548</identifier><identifier>EISSN: 2375-2548</identifier><identifier>DOI: 10.1126/sciadv.1500845</identifier><identifier>PMID: 26601142</identifier><language>eng</language><publisher>United States: American Association for the Advancement of Science</publisher><subject>Cancer Immunotherapy ; SciAdv r-articles</subject><ispartof>Science advances, 2015-11, Vol.1 (10), p.e1500845-e1500845</ispartof><rights>Copyright © 2015, The Authors 2015 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640592/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640592/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26601142$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharma, Madhav D</creatorcontrib><creatorcontrib>Shinde, Rahul</creatorcontrib><creatorcontrib>McGaha, Tracy L</creatorcontrib><creatorcontrib>Huang, Lei</creatorcontrib><creatorcontrib>Holmgaard, Rikke B</creatorcontrib><creatorcontrib>Wolchok, Jedd D</creatorcontrib><creatorcontrib>Mautino, Mario R</creatorcontrib><creatorcontrib>Celis, Esteban</creatorcontrib><creatorcontrib>Sharpe, Arlene H</creatorcontrib><creatorcontrib>Francisco, Loise M</creatorcontrib><creatorcontrib>Powell, Jonathan D</creatorcontrib><creatorcontrib>Yagita, Hideo</creatorcontrib><creatorcontrib>Mellor, Andrew L</creatorcontrib><creatorcontrib>Blazar, Bruce R</creatorcontrib><creatorcontrib>Munn, David H</creatorcontrib><title>The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment</title><title>Science advances</title><addtitle>Sci Adv</addtitle><description>The tumor microenvironment is profoundly immunosuppressive. We show that multiple tumor types create intratumoral immune suppression driven by a specialized form of regulatory T cell (Treg) activation dependent on the PTEN (phosphatase and tensin homolog) lipid phosphatase. PTEN acted to stabilize Tregs in tumors, preventing them from reprogramming into inflammatory effector cells. In mice with a Treg-specific deletion of PTEN, tumors grew slowly, were inflamed, and could not create an immunosuppressive tumor microenvironment. In normal mice, exposure to apoptotic tumor cells rapidly elicited PTEN-expressing Tregs, and PTEN-deficient mice were unable to maintain tolerance to apoptotic cells. In wild-type mice with large established tumors, pharmacologic inhibition of PTEN after chemotherapy or immunotherapy profoundly reconfigured the tumor microenvironment, changing it from a suppressive to an inflammatory milieu, and tumors underwent rapid regression. Thus, the immunosuppressive milieu in tumors must be actively maintained, and tumors become susceptible to immune attack if the PTEN pathway in Tregs is disrupted.</description><subject>Cancer Immunotherapy</subject><subject>SciAdv r-articles</subject><issn>2375-2548</issn><issn>2375-2548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVkE1Lw0AQhhdRbKm9epQ9emnd3exukosgpX5AUQ8RvIVJMmlXkmzcTSL990asopeZYT6ed3gJOedsybnQVz43UAxLrhiLpDoiUxGEaiGUjI7_1BMy9_6NMcal1orHp2QitGacSzElr8kO6XOyfqQtdLsP2FPT0MTh1lPjKdDcmc7kUNHCmQEdtSXtxgvft61D78ce7fraOlqb3FlsBuNsU2PTnZGTEiqP80OekZfbdbK6X2ye7h5WN5tFyyPeLbIw5mGZlVpKHcUYB1oKCARwrULNWKYkikwiMiwhLMafxwiiDCGWRVYoHszI9Te37bMai3yUdlClrTM1uH1qwaT_J43ZpVs7pFJLpmIxAi4PAGffe_RdWhufY1VBg7b3KQ9l_OWWluPqxV-tX5EfO4NP0-R6Jw</recordid><startdate>20151101</startdate><enddate>20151101</enddate><creator>Sharma, Madhav D</creator><creator>Shinde, Rahul</creator><creator>McGaha, Tracy L</creator><creator>Huang, Lei</creator><creator>Holmgaard, Rikke B</creator><creator>Wolchok, Jedd D</creator><creator>Mautino, Mario R</creator><creator>Celis, Esteban</creator><creator>Sharpe, Arlene H</creator><creator>Francisco, Loise M</creator><creator>Powell, Jonathan D</creator><creator>Yagita, Hideo</creator><creator>Mellor, Andrew L</creator><creator>Blazar, Bruce R</creator><creator>Munn, David H</creator><general>American Association for the Advancement of Science</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20151101</creationdate><title>The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment</title><author>Sharma, Madhav D ; Shinde, Rahul ; McGaha, Tracy L ; Huang, Lei ; Holmgaard, Rikke B ; Wolchok, Jedd D ; Mautino, Mario R ; Celis, Esteban ; Sharpe, Arlene H ; Francisco, Loise M ; Powell, Jonathan D ; Yagita, Hideo ; Mellor, Andrew L ; Blazar, Bruce R ; Munn, David H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p181t-b7917fbf644689e93642a32a1657600b54e2b4ee0efa7d114a7da2f7a94dbd513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Cancer Immunotherapy</topic><topic>SciAdv r-articles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharma, Madhav D</creatorcontrib><creatorcontrib>Shinde, Rahul</creatorcontrib><creatorcontrib>McGaha, Tracy L</creatorcontrib><creatorcontrib>Huang, Lei</creatorcontrib><creatorcontrib>Holmgaard, Rikke B</creatorcontrib><creatorcontrib>Wolchok, Jedd D</creatorcontrib><creatorcontrib>Mautino, Mario R</creatorcontrib><creatorcontrib>Celis, Esteban</creatorcontrib><creatorcontrib>Sharpe, Arlene H</creatorcontrib><creatorcontrib>Francisco, Loise M</creatorcontrib><creatorcontrib>Powell, Jonathan D</creatorcontrib><creatorcontrib>Yagita, Hideo</creatorcontrib><creatorcontrib>Mellor, Andrew L</creatorcontrib><creatorcontrib>Blazar, Bruce R</creatorcontrib><creatorcontrib>Munn, David H</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Science advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharma, Madhav D</au><au>Shinde, Rahul</au><au>McGaha, Tracy L</au><au>Huang, Lei</au><au>Holmgaard, Rikke B</au><au>Wolchok, Jedd D</au><au>Mautino, Mario R</au><au>Celis, Esteban</au><au>Sharpe, Arlene H</au><au>Francisco, Loise M</au><au>Powell, Jonathan D</au><au>Yagita, Hideo</au><au>Mellor, Andrew L</au><au>Blazar, Bruce R</au><au>Munn, David H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment</atitle><jtitle>Science advances</jtitle><addtitle>Sci Adv</addtitle><date>2015-11-01</date><risdate>2015</risdate><volume>1</volume><issue>10</issue><spage>e1500845</spage><epage>e1500845</epage><pages>e1500845-e1500845</pages><issn>2375-2548</issn><eissn>2375-2548</eissn><abstract>The tumor microenvironment is profoundly immunosuppressive. We show that multiple tumor types create intratumoral immune suppression driven by a specialized form of regulatory T cell (Treg) activation dependent on the PTEN (phosphatase and tensin homolog) lipid phosphatase. PTEN acted to stabilize Tregs in tumors, preventing them from reprogramming into inflammatory effector cells. In mice with a Treg-specific deletion of PTEN, tumors grew slowly, were inflamed, and could not create an immunosuppressive tumor microenvironment. In normal mice, exposure to apoptotic tumor cells rapidly elicited PTEN-expressing Tregs, and PTEN-deficient mice were unable to maintain tolerance to apoptotic cells. In wild-type mice with large established tumors, pharmacologic inhibition of PTEN after chemotherapy or immunotherapy profoundly reconfigured the tumor microenvironment, changing it from a suppressive to an inflammatory milieu, and tumors underwent rapid regression. Thus, the immunosuppressive milieu in tumors must be actively maintained, and tumors become susceptible to immune attack if the PTEN pathway in Tregs is disrupted.</abstract><cop>United States</cop><pub>American Association for the Advancement of Science</pub><pmid>26601142</pmid><doi>10.1126/sciadv.1500845</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2375-2548 |
ispartof | Science advances, 2015-11, Vol.1 (10), p.e1500845-e1500845 |
issn | 2375-2548 2375-2548 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4640592 |
source | DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Cancer Immunotherapy SciAdv r-articles |
title | The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T23%3A08%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20PTEN%20pathway%20in%20Tregs%20is%20a%20critical%20driver%20of%20the%20suppressive%20tumor%20microenvironment&rft.jtitle=Science%20advances&rft.au=Sharma,%20Madhav%20D&rft.date=2015-11-01&rft.volume=1&rft.issue=10&rft.spage=e1500845&rft.epage=e1500845&rft.pages=e1500845-e1500845&rft.issn=2375-2548&rft.eissn=2375-2548&rft_id=info:doi/10.1126/sciadv.1500845&rft_dat=%3Cproquest_pubme%3E1749601164%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1749601164&rft_id=info:pmid/26601142&rfr_iscdi=true |